Capricor Therapeutics, Inc. (CAPR) Stock Chart - Revenue & Earnings | Quarter Chart

📊 Income Statement

Revenue by Product

Revenue by Geography

Revenue, Gross Profit, Operating and Net Income

Margin (%)

Operating Expenses

Research And Development ExpensesGeneral And Administrative ExpensesOther Expenses
05M10M15M20M25M30M35M40MQ1 2025Q2 2025Q3 2025Q4 2025Q1 2026

EBITDA

EBITDA
-50M-44M-37M-31M-25M-19M-12M-6M1Q1 2025Q2 2025Q3 2025Q4 2025Q1 2026

EPS

Revenue Variation (%)

Revenue Variation
-200-175-150-125-100-74-49-241Q1 2025

Income Variation (%)

Gross Profit VariationOperating Income VariationNet Income Variation
02505007501K1K2K2K2KQ1 2025Q2 2025Q3 2025Q4 2025Q1 2026

Revenue YoY Variation (%)

Revenue YoY Variation
-200-175-150-125-100-74-49-241Q1 2025Q2 2025Q3 2025Q4 2025

Income YoY Variation (%)

Gross Profit YoY VariationOperating Income YoY VariationNet Income YoY Variation
088175262350438525612700Q1 2025Q2 2025Q3 2025Q4 2025Q1 2026

Price-to-Earning Ratio

P/E Ratio
-20-17-15-12-10-7-4-21Q1 2025Q2 2025Q3 2025Q4 2025Q1 2026

Income Breakdown

Per Share Metrics

Operating IncomeInterest IncomeTotal Other Income Expenses NetNet Income
0875K2M3M4M4M5M6M7MQ1 2025Q2 2025Q3 2025Q4 2025Q1 2026

Expense Ratios

💰 Cash Flow Statement

Operating Cash Flow

Free Cash Flow

Cash Flow to Debt Ratio

Cash At End Of Period
050M100M150M200M250M300M350M400MQ1 2025Q2 2025Q3 2025Q4 2025Q1 2026
🏦 Balance Sheet
📈 Key Metrics